GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹45 Cr | ₹40 Cr | ₹30 Cr | ₹24 Cr | ₹19 Cr |
What is the latest Total Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹19 Cr |
How is Total Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 10.54 | |
| Mar2024 | ₹40 Cr | 36.57 | |
| Mar2023 | ₹30 Cr | 21.91 | |
| Mar2022 | ₹24 Cr | 27.25 | |
| Mar2021 | ₹19 Cr | - | |
Compare Total Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹287.6 Cr | -4.8% | -8.7% | -5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -4.8% |
-8.7% |
-5% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses